Cargando…

Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma

BACKGROUND: Primary central nervous system lymphoma (PCNSL), an aggressive type of non-Hodgkin lymphoma, has a poor prognosis. Currently available prognostic scoring systems are inadequate. We therefore aimed to investigate the predictive values of complete blood counts (CBCs) in PCNSL. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yuhua, Liu, Yiping, Zhong, Meizuo, Wang, Leyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033023/ https://www.ncbi.nlm.nih.gov/pubmed/33842320 http://dx.doi.org/10.3389/fonc.2021.618694

Ejemplares similares

A Risk Model Composed of Complete Blood Count, BRAF V600E and MAP2K1 Predicts Inferior Prognosis of Langerhans Cell Histiocytosis in Children
por: Wang, Leyuan, et al.
Publicado: (2022)

The Role and Underlying Mechanism of Exosomal CA1 in Chemotherapy Resistance in Diffuse Large B Cell Lymphoma
por: Feng, Yuhua, et al.
Publicado: (2020)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
por: Li, Philippa, et al.
Publicado: (2021)

Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
por: Zhou, Yangying, et al.
Publicado: (2018)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma
por: Zhou, Xiaolan, et al.
Publicado: (2020)

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside
por: Shao, Liang, et al.
Publicado: (2021)

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
por: Luo, Qian, et al.
Publicado: (2021)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma  with Peripheral Nerve Involvement:  Case Report
por: Mori, Yoshimasa, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Local Control of Primary Dural Central Nervous System Lymphoma Achieved With Radiotherapy
por: Vallejo, Alexandra, et al.
Publicado: (2021)

Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing
por: Wei, Boyuan, et al.
Publicado: (2021)

Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
por: Shen, Jing, et al.
Publicado: (2022)

Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
por: Iorio-Morin, Christian, et al.
Publicado: (2021)

Comparison of Radiomics-Based Machine-Learning Classifiers in Diagnosis of Glioblastoma From Primary Central Nervous System Lymphoma
por: Chen, Chaoyue, et al.
Publicado: (2020)

MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2021)

Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: A case report
por: Feng, Yuhua, et al.
Publicado: (2018)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
por: Mocikova, Heidi, et al.
Publicado: (2022)

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
por: Tu, Sanfang, et al.
Publicado: (2019)

The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2020)

Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
por: Tang, Dongsheng, et al.
Publicado: (2022)

Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study
por: Chi, Kaiyi, et al.
Publicado: (2023)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Primary Central Nervous System Lymphoma (PCNSL): Analysis of Treatment by Gamma Knife Radiosurgery and Chemotherapy in a Prospective, Observational Study
por: Alvarez-Pinzon, Andres M, et al.
Publicado: (2016)

Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study
por: Guan, Tianwang, et al.
Publicado: (2021)

Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
por: Yang, Chuanwei, et al.
Publicado: (2022)

Recent Advances in Treatment of Primary Central Nervous System Lymphoma
por: Nayak, Lakshmi, et al.
Publicado: (2013)

Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma
por: Ma'koseh, Mohammad, et al.
Publicado: (2021)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

mTORC1 signaling in primary central nervous system lymphoma
por: Nitta, Naoki, et al.
Publicado: (2016)

Differentiation Between Primary Central Nervous System Lymphoma and Atypical Glioblastoma Based on MRI Morphological Feature and Signal Intensity Ratio: A Retrospective Multicenter Study
por: Han, Yu, et al.
Publicado: (2022)

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study
por: Tariciotti, Leonardo, et al.
Publicado: (2022)

Cardiovascular Outcomes in the Patients With Primary Central Nervous System Lymphoma: A Multi-Registry Based Cohort Study of 4,038 Cases
por: Qiu, Zicong, et al.
Publicado: (2021)

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
por: Ma, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ll0ajsi7dj25i2eoebhsoj6b2p